Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	eye photoreceptor cell fate commitment	OTX2 CASZ1	3.40e-05	3	70	2	GO:0042706
GeneOntologyBiologicalProcess	response to iron ion starvation	HFE DELE1	3.40e-05	3	70	2	GO:1990641
GeneOntologyBiologicalProcess	photoreceptor cell fate commitment	OTX2 CASZ1	3.40e-05	3	70	2	GO:0046552
GeneOntologyCellularComponent	Golgi lumen	MUC3B MUC15 NCAN MUC19 MUC16 MUC5B MUC3A	9.61e-08	109	72	7	GO:0005796
GeneOntologyCellularComponent	cell surface	HFE TREML4 NLGN4X HLA-C SPN CD44 PKHD1 MUC16 ADAMTS13 TMPRSS11F DCC ADGRE2 CNTN2	9.56e-05	1111	72	13	GO:0009986
GeneOntologyCellularComponent	recycling endosome	HFE SLC9A9 HLA-C TPP1 GNAS RAB11FIP1	1.17e-04	222	72	6	GO:0055037
GeneOntologyCellularComponent	external encapsulating structure	MXRA5 HMCN2 AEBP1 SPN COL20A1 NCAN MUC5B ADAMTS13 PKHD1L1	4.17e-04	658	72	9	GO:0030312
GeneOntologyCellularComponent	MHC class I protein complex	HFE HLA-C	5.17e-04	10	72	2	GO:0042612
GeneOntologyCellularComponent	side of membrane	EPN3 HFE HLA-C SPN CD44 PKHD1 MUC16 GNAS ADGRE2 CNTN2	8.00e-04	875	72	10	GO:0098552
Domain	Ig-like_fold	HFE MXRA5 TREML4 HMCN2 HLA-C NFATC2 COL20A1 NCAN PKHD1 RIMBP2 NECTIN3 KIR2DL4 DCC PKHD1L1 CNTN2	2.73e-08	706	68	15	IPR013783
Domain	-	HFE MXRA5 TREML4 HLA-C NFATC2 COL20A1 NCAN PKHD1 RIMBP2 NECTIN3 KIR2DL4 DCC PKHD1L1 CNTN2	9.21e-08	663	68	14	2.60.40.10
Domain	SEA	MUC3B MUC16 TMPRSS11F MUC3A	1.56e-07	14	68	4	SM00200
Domain	SEA	MUC3B MUC16 TMPRSS11F MUC3A	1.35e-06	23	68	4	PS50024
Domain	SEA_dom	MUC3B MUC16 TMPRSS11F MUC3A	1.35e-06	23	68	4	IPR000082
Domain	IG_LIKE	HFE MXRA5 TREML4 HMCN2 HLA-C NCAN NECTIN3 KIR2DL4 DCC CNTN2	1.07e-05	491	68	10	PS50835
Domain	DUF4587	C21orf58 PRR29	1.31e-05	2	68	2	IPR027904
Domain	DUF4587	C21orf58 PRR29	1.31e-05	2	68	2	PF15248
Domain	Ig-like_dom	HFE MXRA5 TREML4 HMCN2 HLA-C NCAN NECTIN3 KIR2DL4 DCC CNTN2	1.32e-05	503	68	10	IPR007110
Domain	IG	MXRA5 TREML4 HMCN2 NCAN NECTIN3 KIR2DL4 DCC MPIG6B CNTN2	2.10e-05	421	68	9	SM00409
Domain	Ig_sub	MXRA5 TREML4 HMCN2 NCAN NECTIN3 KIR2DL4 DCC MPIG6B CNTN2	2.10e-05	421	68	9	IPR003599
Domain	VWC_out	MUC19 MUC5B VWCE	4.29e-05	19	68	3	SM00215
Domain	SEA	MUC3B MUC16 TMPRSS11F	6.76e-05	22	68	3	PF01390
Domain	G8	PKHD1 PKHD1L1	7.80e-05	4	68	2	PF10162
Domain	G8_domain	PKHD1 PKHD1L1	7.80e-05	4	68	2	IPR019316
Domain	G8	PKHD1 PKHD1L1	7.80e-05	4	68	2	PS51484
Domain	G8	PKHD1 PKHD1L1	7.80e-05	4	68	2	SM01225
Domain	UIM	EPN3 RBSN ZFAND2B	8.84e-05	24	68	3	PS50330
Domain	UIM_dom	EPN3 RBSN ZFAND2B	1.00e-04	25	68	3	IPR003903
Domain	IPT	NFATC2 PKHD1 PKHD1L1	1.27e-04	27	68	3	SM00429
Domain	TIG	NFATC2 PKHD1 PKHD1L1	1.93e-04	31	68	3	PF01833
Domain	PbH1	PKHD1 PKHD1L1	1.94e-04	6	68	2	SM00710
Domain	PbH1	PKHD1 PKHD1L1	1.94e-04	6	68	2	IPR006626
Domain	IPT	NFATC2 PKHD1 PKHD1L1	2.12e-04	32	68	3	IPR002909
Domain	EGF_3	MUC3B HMCN2 NCAN ADGRE2 VWCE MUC3A	2.12e-04	235	68	6	PS50026
Domain	EGF-like_dom	MUC3B HMCN2 NCAN ADGRE2 VWCE MUC3A	2.90e-04	249	68	6	IPR000742
Domain	EGF_1	MUC3B HMCN2 NCAN ADGRE2 VWCE MUC3A	3.29e-04	255	68	6	PS00022
Domain	VWC	MUC19 MUC5B VWCE	3.55e-04	38	68	3	SM00214
Domain	VWFC_2	MUC19 MUC5B VWCE	3.55e-04	38	68	3	PS50184
Domain	Pectin_lyase_fold/virulence	PKHD1 PKHD1L1	3.61e-04	8	68	2	IPR011050
Domain	EGF-like_CS	MUC3B HMCN2 NCAN ADGRE2 VWCE MUC3A	3.73e-04	261	68	6	IPR013032
Domain	EGF_2	MUC3B HMCN2 NCAN ADGRE2 VWCE MUC3A	4.04e-04	265	68	6	PS01186
Domain	EGF_Ca-bd_CS	HMCN2 NCAN ADGRE2 VWCE	4.32e-04	97	68	4	IPR018097
Domain	EGF_CA	HMCN2 NCAN ADGRE2 VWCE	4.66e-04	99	68	4	PS01187
Domain	VWF_dom	MUC19 MUC5B VWCE	4.79e-04	42	68	3	IPR001007
Domain	ASX_HYDROXYL	HMCN2 NCAN ADGRE2 VWCE	4.85e-04	100	68	4	PS00010
Domain	EGF-type_Asp/Asn_hydroxyl_site	HMCN2 NCAN ADGRE2 VWCE	6.04e-04	106	68	4	IPR000152
Domain	TIL	MUC19 MUC5B	8.42e-04	12	68	2	PF01826
Domain	Carbonic_anhydrase_a-class_CS	CA13 CA5A	8.42e-04	12	68	2	IPR018338
Domain	C8	MUC19 MUC5B	8.42e-04	12	68	2	PF08742
Domain	LINK	NCAN CD44	9.93e-04	13	68	2	SM00445
Domain	Unchr_dom_Cys-rich	MUC19 MUC5B	9.93e-04	13	68	2	IPR014853
Domain	Link_dom	NCAN CD44	9.93e-04	13	68	2	IPR000538
Domain	C8	MUC19 MUC5B	9.93e-04	13	68	2	SM00832
Domain	Xlink	NCAN CD44	9.93e-04	13	68	2	PF00193
Domain	LINK_1	NCAN CD44	9.93e-04	13	68	2	PS01241
Domain	LINK_2	NCAN CD44	9.93e-04	13	68	2	PS50963
Domain	EGF_CA	HMCN2 NCAN ADGRE2 VWCE	1.02e-03	122	68	4	SM00179
Domain	EGF-like_Ca-bd_dom	HMCN2 NCAN ADGRE2 VWCE	1.09e-03	124	68	4	IPR001881
Domain	K_chnl_volt-dep_EAG/ELK/ERG	HCN4 CNGA1	1.16e-03	14	68	2	IPR003938
Domain	TIL_dom	MUC19 MUC5B	1.16e-03	14	68	2	IPR002919
Domain	Carbonic_anhydrase_a-class	CA13 CA5A	1.33e-03	15	68	2	IPR023561
Domain	-	MUC16 TMPRSS11F	1.33e-03	15	68	2	3.30.70.960
Domain	ALPHA_CA_1	CA13 CA5A	1.33e-03	15	68	2	PS00162
Domain	VWD	MUC19 MUC5B	1.52e-03	16	68	2	SM00216
Domain	VWF_type-D	MUC19 MUC5B	1.52e-03	16	68	2	IPR001846
Domain	cNMP-bd_CS	HCN4 CNGA1	1.52e-03	16	68	2	IPR018488
Domain	VWFD	MUC19 MUC5B	1.52e-03	16	68	2	PS51233
Domain	VWD	MUC19 MUC5B	1.52e-03	16	68	2	PF00094
Domain	EGF	MUC3B NCAN ADGRE2 VWCE MUC3A	1.65e-03	235	68	5	SM00181
Domain	ALPHA_CA_2	CA13 CA5A	1.71e-03	17	68	2	PS51144
Domain	Carb_anhydrase	CA13 CA5A	1.71e-03	17	68	2	PF00194
Domain	Carb_anhydrase	CA13 CA5A	1.71e-03	17	68	2	SM01057
Domain	-	CA13 CA5A	1.71e-03	17	68	2	3.10.200.10
Domain	Carbonic_anhydrase_a	CA13 CA5A	1.71e-03	17	68	2	IPR001148
Domain	UIM	EPN3 ZFAND2B	1.92e-03	18	68	2	PF02809
Domain	CTCK_1	MUC19 MUC5B	1.92e-03	18	68	2	PS01185
Domain	UIM	EPN3 ZFAND2B	2.62e-03	21	68	2	SM00726
Domain	MHC_I	HFE HLA-C	2.62e-03	21	68	2	PF00129
Domain	MHC_I_a_a1/a2	HFE HLA-C	2.62e-03	21	68	2	IPR001039
Domain	CT	MUC19 MUC5B	2.88e-03	22	68	2	SM00041
Domain	fn3	COL20A1 RIMBP2 DCC CNTN2	2.89e-03	162	68	4	PF00041
Domain	-	HFE HLA-C	3.42e-03	24	68	2	3.30.500.10
Domain	MHC_I-like_Ag-recog	HFE HLA-C	3.42e-03	24	68	2	IPR011161
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC15 MUC16 MUC5B MUC3A	2.27e-07	16	49	4	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC15 MUC16 MUC5B MUC3A	2.97e-07	17	49	4	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC15 MUC19 MUC16 MUC5B	7.38e-07	21	49	4	MM15706
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC15 MUC16 MUC5B MUC3A	1.09e-06	23	49	4	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC15 MUC16 MUC5B MUC3A	1.82e-06	26	49	4	M27483
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC15 MUC16 MUC5B ADAMTS13 MUC3A	3.64e-06	68	49	5	M27303
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC15 NCAN MUC16 MUC5B ADAMTS13 MUC3A	9.58e-06	143	49	6	M27275
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC15 MUC19 MUC16 MUC5B ADAMTS13	3.67e-05	109	49	5	MM15164
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC15 MUC16 MUC5B ADAMTS13 MUC3A	4.00e-05	111	49	5	M27416
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC15 MUC19 MUC16 MUC5B	5.44e-05	60	49	4	MM15636
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC15 MUC16 MUC5B MUC3A	6.20e-05	62	49	4	M546
Pathway	KEGG_CELL_ADHESION_MOLECULES_CAMS	NLGN4X HLA-C SPN NECTIN3 CNTN2	9.47e-05	133	49	5	M16476
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	NFATC2 MUC15 MUC16 MUC5B MUC3A	1.21e-04	140	49	5	M27484
Pathway	REACTOME_DISEASES_OF_METABOLISM	MUC15 NCAN MUC16 MUC5B ADAMTS13 MUC3A	2.16e-04	250	49	6	M27554
Pathway	REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE	CA13 CA5A	7.64e-04	12	49	2	M671
Pathway	REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE	CA13 CA5A	7.64e-04	12	49	2	MM14574
Pathway	SA_MMP_CYTOKINE_CONNECTION	SPN CD44	1.21e-03	15	49	2	M11736
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC15 MUC19 MUC16 MUC5B MUC3A	3.41e-10	18	75	5	18834073
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16 MUC5B	1.92e-07	6	75	3	19110483
Pubmed	Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis.	SPN CD44 ADGRE2	3.45e-06	14	75	3	19299737
Pubmed	Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B.	MUC3B MUC3A	4.59e-06	2	75	2	10973822
Pubmed	A repressor of GATA-mediated negative feedback mechanism of T cell activation.	ZBTB32 NFATC2	4.59e-06	2	75	2	14688323
Pubmed	Hyaluronan fragments/CD44 mediate oxidative stress-induced MUC5B up-regulation in airway epithelium.	CD44 MUC5B	4.59e-06	2	75	2	18757307
Pubmed	TAG-1/axonin-1 is a high-affinity ligand of neurocan, phosphacan/protein-tyrosine phosphatase-zeta/beta, and N-CAM.	NCAN CNTN2	4.59e-06	2	75	2	8663515
Pubmed	Initiation of transcription of the MUC3A human intestinal mucin from a TATA-less promoter and comparison with the MUC3B amino terminus.	MUC3B MUC3A	4.59e-06	2	75	2	12958310
Pubmed	MUC3 human intestinal mucin. Analysis of gene structure, the carboxyl terminus, and a novel upstream repetitive region.	MUC3B MUC3A	4.59e-06	2	75	2	9334251
Pubmed	Molecular cloning of cDNAs derived from a novel human intestinal mucin gene.	MUC3B MUC3A	4.59e-06	2	75	2	2393399
Pubmed	Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn's disease.	MUC3B MUC3A	4.59e-06	2	75	2	11289722
Pubmed	The MUC3 gene encodes a transmembrane mucin and is alternatively spliced.	MUC3B MUC3A	4.59e-06	2	75	2	10405327
Pubmed	Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma.	CD44 MUC16	1.37e-05	3	75	2	12893366
Pubmed	Expression of mucin 3 and mucin 5AC in arthritic synovial tissue.	MUC3B MUC3A	1.37e-05	3	75	2	18163520
Pubmed	Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family.	CA13 CA5A	1.37e-05	3	75	2	14600151
Pubmed	Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin.	MUC3B MUC3A	1.37e-05	3	75	2	10512748
Pubmed	CD43 Functions as an E-Selectin Ligand for Th17 Cells In Vitro and Is Required for Rolling on the Vascular Endothelium and Th17 Cell Recruitment during Inflammation In Vivo.	SPN CD44	1.37e-05	3	75	2	26700769
Pubmed	Age-related defects in moesin/ezrin cytoskeletal signals in mouse CD4 T cells.	SPN CD44	1.37e-05	3	75	2	17982027
Pubmed	NFAT1 mediates placental growth factor-induced myelomonocytic cell recruitment via the induction of TNF-alpha.	NFATC2 PGF	1.37e-05	3	75	2	20097868
Pubmed	The in vivo regulation of heart rate in the murine sinoatrial node by stimulatory and inhibitory heterotrimeric G proteins.	HCN4 GNAS	1.37e-05	3	75	2	23697798
Pubmed	DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.	MUC16 MUC5B	1.37e-05	3	75	2	27230679
Pubmed	A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.	HLA-C KIR2DL4	2.75e-05	4	75	2	10190900
Pubmed	Extension of long leading processes and neuronal migration in the mammalian brain directed by the chemoattractant netrin-1.	DCC CNTN2	2.75e-05	4	75	2	10595513
Pubmed	Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway.	SPN CD44	2.75e-05	4	75	2	8858161
Pubmed	NCK is critical for the development of deleted in colorectal cancer (DCC) sensitive spinal circuits.	DCC CNTN2	2.75e-05	4	75	2	25913325
Pubmed	Loss of Dcc in the spinal cord is sufficient to cause a deficit in lateralized motor control and the switch to a hopping gait.	DCC CNTN2	2.75e-05	4	75	2	28691197
Pubmed	Aberrant development of hippocampal circuits and altered neural activity in netrin 1-deficient mice.	DCC CNTN2	2.75e-05	4	75	2	11044395
Pubmed	Insights into PCSK9-LDLR Regulation and Trafficking via the Differential Functions of MHC-I Proteins HFE and HLA-C.	HFE HLA-C	2.75e-05	4	75	2	38786080
Pubmed	HIV-1 Gag associates with specific uropod-directed microdomains in a manner dependent on its MA highly basic region.	SPN CD44	2.75e-05	4	75	2	23536680
Pubmed	Sialomucin CD43 regulates T helper type 17 cell intercellular adhesion molecule 1 dependent adhesion, apical migration and transendothelial migration.	SPN CD44	2.75e-05	4	75	2	30690734
Pubmed	c-Jun N-terminal kinase 1 (JNK1) is required for coordination of netrin signaling in axon guidance.	DCC CNTN2	2.75e-05	4	75	2	23223444
Pubmed	Aberrant trajectory of thalamocortical axons associated with abnormal localization of neurocan immunoreactivity in the cerebral neocortex of reeler mutant mice.	NCAN CNTN2	2.75e-05	4	75	2	16324103
Pubmed	Defining the ligand specificity of the deleted in colorectal cancer (DCC) receptor.	DCC CNTN2	4.57e-05	5	75	2	24400119
Pubmed	Amyloid precursor protein regulates netrin-1-mediated commissural axon outgrowth.	DCC CNTN2	4.57e-05	5	75	2	22782894
Pubmed	The cytoplasmic tail of fibrocystin contains a ciliary targeting sequence.	PKHD1 PKHD1L1	4.57e-05	5	75	2	20048263
Pubmed	Basic motifs target PSGL-1, CD43, and CD44 to plasma membrane sites where HIV-1 assembles.	SPN CD44	4.57e-05	5	75	2	25320329
Pubmed	Normal function of the transcription factor NFAT1 in wasted mice. Chromosome localization of NFAT1 gene.	NFATC2 GNAS	4.57e-05	5	75	2	8973343
Pubmed	Distinct expression of select and transcriptome-wide isolated 3'UTRs suggests critical roles in development and transition states.	OTX2 DCC CNTN2	5.02e-05	33	75	3	33951080
Pubmed	Syntaxin 1 is required for DCC/Netrin-1-dependent chemoattraction of migrating neurons from the lower rhombic lip.	DCC CNTN2	6.84e-05	6	75	2	22946563
Pubmed	Serine protease autotransporters from Shigella flexneri and pathogenic Escherichia coli target a broad range of leukocyte glycoproteins.	SPN CD44	6.84e-05	6	75	2	21768350
Pubmed	Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2.	SPN CD44	6.84e-05	6	75	2	9472040
Pubmed	Neural migration. Structures of netrin-1 bound to two receptors provide insight into its axon guidance mechanism.	DCC CNTN2	6.84e-05	6	75	2	24876346
Pubmed	Ventral midline cells are required for the local control of commissural axon guidance in the mouse spinal cord.	DCC CNTN2	6.84e-05	6	75	2	10409510
Pubmed	Genetic analysis of DSCAM's role as a Netrin-1 receptor in vertebrates.	DCC CNTN2	6.84e-05	6	75	2	22238077
Pubmed	A genomic atlas of mouse hypothalamic development.	OTX2 NCAN NECTIN3 BCOR PARM1	8.37e-05	205	75	5	20436479
Pubmed	Netrin 1 and Dcc signalling are required for confinement of central axons within the central nervous system.	DCC CNTN2	9.57e-05	7	75	2	24449837
Pubmed	Chemokine receptor CXCR7 non-cell-autonomously controls pontine neuronal migration and nucleus formation.	DCC CNTN2	9.57e-05	7	75	2	32678266
Pubmed	The diversity of KIR gene in Chinese Northern Han population and the impact of donor KIR and patient HLA genotypes on outcome following HLA-identical sibling allogeneic hematopoietic stem cell transplantation for hematological malignancy in Chinese people.	HLA-C KIR2DL4	9.57e-05	7	75	2	18347914
Pubmed	Progenitors of dorsal commissural interneurons are defined by MATH1 expression.	DCC CNTN2	9.57e-05	7	75	2	9449674
Pubmed	Molecular typing of human leukocyte antigen and related polymorphisms following whole genome amplification.	HFE HLA-C	9.57e-05	7	75	2	15304010
Pubmed	Differential roles of Netrin-1 and its receptor DCC in inferior olivary neuron migration.	DCC CNTN2	9.57e-05	7	75	2	19409494
Pubmed	Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system.	DCC CNTN2	9.57e-05	7	75	2	8978605
Pubmed	Arf4 is required for Mammalian development but dispensable for ciliary assembly.	PKHD1 PKHD1L1	9.57e-05	7	75	2	24586199
Pubmed	A tug of war between DCC and ROBO1 signaling during commissural axon guidance.	DCC CNTN2	9.57e-05	7	75	2	37149867
Pubmed	Scc-1, a novel colon cancer susceptibility gene in the mouse: linkage to CD44 (Ly-24, Pgp-1) on chromosome 2.	CD44 DCC	9.57e-05	7	75	2	1347918
Pubmed	Netrin-1/DCC Signaling Differentially Regulates the Migration of Pax7, Nkx6.1, Irx2, Otp, and Otx2 Cell Populations in the Developing Interpeduncular Nucleus.	OTX2 DCC	9.57e-05	7	75	2	33195252
Pubmed	Genetic composition of the recombinant congenic strains.	HLA-C CD44 DCC	9.68e-05	41	75	3	8903730
Pubmed	Engrailed-1 and netrin-1 regulate axon pathfinding by association interneurons that project to motor neurons.	DCC CNTN2	1.27e-04	8	75	2	10477289
Pubmed	Th1 Cells Rolling on Selectins Trigger DAP12-Dependent Signals That Activate Integrin αLβ2.	SPN CD44	1.27e-04	8	75	2	31757864
Pubmed	Requirement for core 2 O-glycans for optimal resistance to helminth infection.	SPN CD44	1.27e-04	8	75	2	23555902
Pubmed	Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene.	DCC CNTN2	1.27e-04	8	75	2	9126737
Pubmed	Adhesion molecule Amigo2 is involved in the fasciculation process of the fasciculus retroflexus.	DCC CNTN2	1.27e-04	8	75	2	35727300
Pubmed	Gradual differentiation and confinement of the cardiac conduction system as indicated by marker gene expression.	HCN4 CNTN2	1.27e-04	8	75	2	31306714
Pubmed	Temporal regulation of axonal repulsion by alternative splicing of a conserved microexon in mammalian Robo1 and Robo2.	DCC CNTN2	1.27e-04	8	75	2	31392959
Pubmed	Mis-expression of L1 on pre-crossing spinal commissural axons disrupts pathfinding at the ventral midline.	DCC CNTN2	1.27e-04	8	75	2	17884558
Pubmed	Revisiting the role of Dcc in visual system development with a novel eye clearing method.	DCC CNTN2	1.27e-04	8	75	2	32096760
Pubmed	Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function.	HFE HLA-C	1.27e-04	8	75	2	16123136
Pubmed	Ndfip Proteins Target Robo Receptors for Degradation and Allow Commissural Axons to Cross the Midline in the Developing Spinal Cord.	DCC CNTN2	1.27e-04	8	75	2	30893602
Pubmed	Distribution of KIR genes in the Czech population.	HLA-C KIR2DL4	1.64e-04	9	75	2	18186800
Pubmed	A new taxonomy of mammalian MHC class I molecules.	HFE HLA-C	1.64e-04	9	75	2	10081226
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	NFATC2 TTLL5 CD44 HELZ2 MUC16 GNAS MUC3A	1.91e-04	552	75	7	10737800
Pubmed	International Union of Pharmacology. LI. Nomenclature and structure-function relationships of cyclic nucleotide-regulated channels.	HCN4 CNGA1	2.04e-04	10	75	2	16382102
Pubmed	Wnt1 Role in the Development of the Habenula and the Fasciculus Retroflexus.	DCC CNTN2	2.04e-04	10	75	2	34722541
Pubmed	Subdomain-mediated axon-axon signaling and chemoattraction cooperate to regulate afferent innervation of the lateral habenula.	DCC CNTN2	2.04e-04	10	75	2	25033181
Pubmed	Heparan sulfate regulates intraretinal axon pathfinding by retinal ganglion cells.	OTX2 DCC	2.49e-04	11	75	2	21743013
Pubmed	Commissural axonal corridors instruct neuronal migration in the mouse spinal cord.	DCC CNTN2	2.49e-04	11	75	2	25960414
Pubmed	Laminar organization of the developing lateral olfactory tract revealed by differential expression of cell recognition molecules.	DCC CNTN2	2.99e-04	12	75	2	15457507
Pubmed	Ptch1 is essential for cochlear marginal cell differentiation and stria vascularis formation.	OTX2 CD44	2.99e-04	12	75	2	38602877
Pubmed	Netrin-1/DCC signaling in commissural axon guidance requires cell-autonomous expression of heparan sulfate.	DCC CNTN2	2.99e-04	12	75	2	17442818
Pubmed	Multiple influences on the migration of precerebellar neurons in the caudal medulla.	DCC CNTN2	2.99e-04	12	75	2	11807023
Pubmed	A systematic quantification of carbonic anhydrase transcripts in the mouse digestive system.	CA13 CA5A	2.99e-04	12	75	2	17362527
Pubmed	CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4.	HLA-C CD44	2.99e-04	12	75	2	9133426
Pubmed	Insm1 promotes endocrine cell differentiation by modulating the expression of a network of genes that includes Neurog3 and Ripply3.	ADGRE2 PGF CASZ1	3.49e-04	63	75	3	25053427
Pubmed	Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon.	NFATC2 CD44	3.52e-04	13	75	2	20139419
Pubmed	Altered midline axon pathways and ectopic neurons in the developing hypothalamus of netrin-1- and DCC-deficient mice.	CD44 DCC	3.52e-04	13	75	2	10559399
Pubmed	A global gene regulatory program and its region-specific regulator partition neurons into commissural and ipsilateral projection types.	DCC CNTN2	3.52e-04	13	75	2	38781326
Pubmed	Rudhira/BCAS3 is essential for mouse development and cardiovascular patterning.	AEBP1 CNTN2	3.52e-04	13	75	2	29618843
Pubmed	OFCD syndrome and extraembryonic defects are revealed by conditional mutation of the Polycomb-group repressive complex 1.1 (PRC1.1) gene BCOR.	OTX2 BCOR	3.52e-04	13	75	2	32692983
Pubmed	NOVA2-mediated RNA regulation is required for axonal pathfinding during development.	DCC CNTN2	4.11e-04	14	75	2	27223325
Pubmed	A simple method for 3D analysis of immunolabeled axonal tracts in a transparent nervous system.	DCC CNTN2	4.73e-04	15	75	2	25456121
Pubmed	Differentially expressed genes in the testicular tissues of adenylyl cyclase 3 knockout mice.	DCC METTL14	4.73e-04	15	75	2	27864010
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	HLA-C KIR2DL4	4.73e-04	15	75	2	20356536
Pubmed	MARCKS Is Necessary for Netrin-DCC Signaling and Corpus Callosum Formation.	DCC CNTN2	4.73e-04	15	75	2	29546593
Pubmed	Variation in a Left Ventricle-Specific Hand1 Enhancer Impairs GATA Transcription Factor Binding and Disrupts Conduction System Development and Function.	HCN4 CNTN2	4.73e-04	15	75	2	31366290
Pubmed	A conserved regulatory logic controls temporal identity in mouse neural progenitors.	OTX2 CASZ1	4.73e-04	15	75	2	25654255
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	HLA-C KIR2DL4	4.73e-04	15	75	2	20643584
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	HLA-C KIR2DL4	4.73e-04	15	75	2	19326408
Pubmed	NOVA regulates Dcc alternative splicing during neuronal migration and axon guidance in the spinal cord.	DCC CNTN2	5.40e-04	16	75	2	27223328
Pubmed	Neurotrophins and netrins require calcineurin/NFAT signaling to stimulate outgrowth of embryonic axons.	NFATC2 DCC	5.40e-04	16	75	2	12787506
Pubmed	Accessory protein-like is essential for IL-18-mediated signaling.	SPN CD44	5.40e-04	16	75	2	15843532
Cytoband	Ensembl 112 genes in cytogenetic band chr20q13	NFATC2 COL20A1 HELZ2 GNAS MYBL2	6.52e-04	422	75	5	chr20q13
Cytoband	Xp22.33	MXRA5 NLGN4X	7.71e-04	25	75	2	Xp22.33
GeneFamily	CD molecules\|Mucins	MUC3B MUC15 MUC19 MUC16 MUC5B MUC3A	1.52e-11	21	49	6	648
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MXRA5 HMCN2 NECTIN3 DCC CNTN2	7.31e-05	161	49	5	593
GeneFamily	Immunoglobulin like domain containing	MXRA5 HMCN2 NECTIN3 DCC CNTN2	1.71e-04	193	49	5	594
GeneFamily	Cyclic nucleotide gated channels	HCN4 CNGA1	3.19e-04	10	49	2	250
GeneFamily	Carbonic anhydrases	CA13 CA5A	1.07e-03	18	49	2	460
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	SPN CD44 NECTIN3 KIR2DL4 ADGRE2	4.16e-03	394	49	5	471
GeneFamily	C1-set domain containing	HFE HLA-C	5.78e-03	42	49	2	591
GeneFamily	Fibronectin type III domain containing	COL20A1 DCC CNTN2	9.30e-03	160	49	3	555
GeneFamily	Adenosine receptors\|V-set domain containing	TREML4 NCAN NECTIN3	9.79e-03	163	49	3	590
Coexpression	NABA_MATRISOME	MXRA5 HMCN2 AEBP1 COL20A1 MUC15 NCAN MUC19 MUC16 MUC5B ADAMTS13 VWCE MUC3A PGF PARM1	9.26e-07	1026	74	14	M5889
Coexpression	NABA_ECM_AFFILIATED	MUC15 MUC19 MUC16 MUC5B MUC3A PARM1	8.76e-06	170	74	6	M5880
Coexpression	NABA_MATRISOME	HMCN2 AEBP1 COL20A1 MUC15 NCAN MUC19 MUC16 MUC5B ADAMTS13 VWCE PGF PARM1	2.39e-05	1008	74	12	MM17056
Coexpression	MIKKELSEN_MEF_ICP_WITH_H3K27ME3	EPN3 HLA-C PRR19 NCAN ARHGAP9 PKHD1L1	4.05e-05	223	74	6	MM838
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZBTB32 MUC16 POU2AF1 DCC PKHD1L1 PARM1 MYBL2	1.79e-08	176	74	7	dc4e939a07bad21ab36181f9588df3fa662f9a92
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1 MUC19 RIMBP2 MUC5B DCC PKHD1L1	2.79e-07	160	74	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1 MUC19 RIMBP2 MUC5B DCC PKHD1L1	2.79e-07	160	74	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	mild_COVID-19_(asymptomatic)-Plasmablast\|World / disease group, cell group and cell class (v2)	ZBTB32 DTL POU2AF1 PKHD1L1 PARM1 MYBL2	3.59e-07	167	74	6	f26ae4de4804a3486502e3df37eabf3dfca688f5
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MUC16 POU2AF1 DCC PKHD1L1 PARM1 MYBL2	4.73e-07	175	74	6	3b5346fba617292de71963b6175e85a4f182fe30
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1 MUC5B ZNF488 DCC PKHD1L1 CNTN2	6.34e-07	184	74	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1 MUC5B ZNF488 DCC PKHD1L1 CNTN2	6.34e-07	184	74	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1 MUC5B ZNF488 DCC PKHD1L1 CNTN2	6.34e-07	184	74	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ZNF704 NFATC2 HLF PKHD1 CA13 CA5A	6.97e-07	187	74	6	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasmablasts\|bone_marrow / Manually curated celltypes from each tissue	ZBTB32 POU2AF1 DCC PKHD1L1 PARM1 MYBL2	7.19e-07	188	74	6	4caae2acd9ec0eb79b7476a1e59f30f39afddcda
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZBTB32 POU2AF1 DCC PKHD1L1 PARM1 MYBL2	7.42e-07	189	74	6	59e6fec454de621119571d4a8ec48be3bf02a32e
ToppCell	severe_COVID-19-Plasmablast\|severe_COVID-19 / disease group, cell group and cell class (v2)	DTL POU2AF1 DCC PKHD1L1 PARM1 MYBL2	7.42e-07	189	74	6	953143b2c2e87a4d8ef033a5fbb155fe62e9c78e
ToppCell	356C-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZBTB32 POU2AF1 DCC PKHD1L1 PARM1 MYBL2	7.42e-07	189	74	6	0994aba7a44577a8943af237c9c3575502d0584c
ToppCell	356C-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZBTB32 POU2AF1 DCC PKHD1L1 PARM1 MYBL2	7.42e-07	189	74	6	d1bd3b5ac32459929e556fb3a4fe8e1e15f6e658
ToppCell	3'_v3-bone_marrow-Lymphocytic_B_plasma\|bone_marrow / Manually curated celltypes from each tissue	ZBTB32 POU2AF1 DCC PKHD1L1 PARM1 MYBL2	7.42e-07	189	74	6	dceb011216deb4ffd830144a53c635c05dff5ec5
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZBTB32 POU2AF1 DCC PKHD1L1 PARM1 MYBL2	7.42e-07	189	74	6	43f25fb7257eab05df921ffcd5a6e49c78a03e3a
ToppCell	COVID-19_Severe-Plasmablast\|World / disease group, cell group and cell class	ZBTB32 DTL POU2AF1 PKHD1L1 PARM1 MYBL2	8.13e-07	192	74	6	a333053fe2bd206c32790916bfc5fce904ab7f57
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZBTB32 DTL POU2AF1 PKHD1L1 PARM1 MYBL2	8.64e-07	194	74	6	297286c57d7ee6338d9cf77b27eb2809378ce15d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZBTB32 DTL POU2AF1 PKHD1L1 PARM1 MYBL2	8.90e-07	195	74	6	533818e89d809f01fbb5c4b57932b76aa5c8f30e
ToppCell	MS-IIF-Lymphocyte-B-Plasmablast\|IIF / Disease, condition lineage and cell class	DTL POU2AF1 ADAMTS13 PKHD1L1 PARM1 MYBL2	9.44e-07	197	74	6	1b5ac53297cc557e08b9e8e511c2385a38f56bd6
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Tpbg_(eccentric_SPN,_dSPN-like_markers)\|Striatum / BrainAtlas - Mouse McCarroll V32	CRYBA1 MUC19 C4orf50 ADAMTS13	1.47e-06	50	74	4	9a54cd5a55ef53f7a8b43fe76c4e0e47b44b8c71
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Tpbg_(eccentric_SPN,_dSPN-like_markers)-\|Striatum / BrainAtlas - Mouse McCarroll V32	CRYBA1 MUC19 C4orf50 ADAMTS13	1.47e-06	50	74	4	cd5e2a8f4fa4a31d0c7a74d5826485e42b3908f7
ToppCell	control-Plasmablast\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	2.56e-06	130	74	5	9fe3c5be8488d341cff38757daf7856c112410d0
ToppCell	10x5'-blood-Lymphocytic_B_plasma\|blood / Manually curated celltypes from each tissue	POU2AF1 DCC PKHD1L1 PARM1 MYBL2	5.16e-06	150	74	5	6bab0a8bf78ed7de9e1b67ede7496488f80f4863
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EPN3 TREML4 NCAN PGF PARM1	5.86e-06	154	74	5	b6e982e341c6cfb6ff80a318078fcb10c36d182f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EPN3 TREML4 NCAN PGF PARM1	5.86e-06	154	74	5	d76fd51a4587decbfe1dde1c8a9b880c5fa18e4a
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HFE ZBTB32 SPN CD44 POU2AF1	7.06e-06	160	74	5	cfd005e98944817458e8ef9e0c436d77f50c1ad1
ToppCell	Control-Lymphocyte-B-Plasmablast\|Control / Disease, Lineage and Cell Type	ZBTB32 DTL POU2AF1 PKHD1L1 PARM1	7.50e-06	162	74	5	67b32c40cc180c5ebbfd901a417b5be469500110
ToppCell	droplet-Fat-Mat-18m-Myeloid-monocyte\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TREML4 CD44 ARHGAP9 RAB11FIP1 ADGRE2	7.96e-06	164	74	5	a27b9b3380f29bb17c9f787423f2591f2b9cf33e
ToppCell	droplet-Kidney-nan-18m-Lymphocytic-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPN CD44 CFAP74 ZNF488 ADGRE2	7.96e-06	164	74	5	731b9c7d6f6ecfb14d4a8705e0ddac9fb460d9a8
ToppCell	control-Plasmablast\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	8.20e-06	165	74	5	61063e0ce61bc92d5d1093be8279af03f650720b
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPN MUC15 DTL POU2AF1 ARHGAP9	8.20e-06	165	74	5	66f0364098d82629aa2ec1dfe0c5ad23de7c2c12
ToppCell	facs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TREML4 SPN CD44 POU2AF1 ADGRE2	8.20e-06	165	74	5	ab6ed7e30096c418e7be2d5eec33feeddd1387d9
ToppCell	mild_COVID-19_(asymptomatic)-Plasmablast\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	ZBTB32 DTL PKHD1L1 PARM1 MYBL2	8.44e-06	166	74	5	0cc3b9681bc000a1b00d3b60f79f16eea1c2e2e1
ToppCell	ICU-SEP-Lymphocyte-B-Plasmablast\|ICU-SEP / Disease, Lineage and Cell Type	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	8.44e-06	166	74	5	98ce43e14133418f676f1c88c001add9e28259a7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	C21orf58 PRR29 DTL MPIG6B MYBL2	8.69e-06	167	74	5	108ae6221c6edc63c0ec42c42471b3a15a594043
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-immature_innate_lymphoid_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NFATC2 SPN PRR29 CD44 CFAP74	8.69e-06	167	74	5	5d1919bea8e5a52ac6fc953caff15509b7142923
ToppCell	droplet-Kidney-nan-24m-Myeloid-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HFE TREML4 SPN CD44 ADGRE2	8.69e-06	167	74	5	2ee1660be117e20f24557522345572d11cbee813
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NFATC2 SPN PRR29 CD44 CFAP74	8.69e-06	167	74	5	d8f497860d48342a3aaaad328f88e4d55ab4faeb
ToppCell	droplet-Kidney-nan-3m-Epithelial-kidney_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HFE TREML4 SPN CD44 ADGRE2	8.95e-06	168	74	5	f45dbcd7753117a3e41e1412bce2100d52fa7fd0
ToppCell	droplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HFE ZBTB32 CD44 POU2AF1 PARM1	9.47e-06	170	74	5	29deb285d5a82c0abcc108012ca42f4b4b4d9e19
ToppCell	droplet-Thymus-nan-21m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HFE ZBTB32 CD44 POU2AF1 PARM1	9.47e-06	170	74	5	dc35d66a9a9fe6cdd7f4ec0fe7efa49d02f2b5b2
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HFE TREML4 SPN BCOR ADGRE2	9.47e-06	170	74	5	8e774af244cfe787fa0ea2b6be0c3c2d00bfe4fc
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HFE TREML4 SPN BCOR ADGRE2	9.47e-06	170	74	5	f5140eb9313c0d1bb31f8a761d9c062c56733a61
ToppCell	10x5'-Lung-Lymphocytic_B_plasma\|Lung / Manually curated celltypes from each tissue	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.00e-05	172	74	5	8156fb6de66a4c92ade703b71c2e9187291e50ef
ToppCell	Healthy/Control-Plasmablast\|World / Disease group and Cell class	DTL POU2AF1 PKHD1L1 PARM1 MYBL2	1.00e-05	172	74	5	d3bfcf5d936152b71cd90f955f9331709edd979e
ToppCell	droplet-Spleen-nan-21m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB32 SPN CD44 GNAS PARM1	1.00e-05	172	74	5	3dc02709c2a6be2155576e5c34e1b0b3ae19b061
ToppCell	BL-critical-LOC-Lymphoid-PC\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DTL POU2AF1 PKHD1L1 PARM1 MYBL2	1.03e-05	173	74	5	90700a876d997f7c0f7b3899dffcda7fdafee547
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TREML4 SPN CD44 ADGRE2 PGF	1.03e-05	173	74	5	c63a615998d13b1725b5767f4ad2ec7e2b61db68
ToppCell	Multiple_Sclerosis-Lymphocyte-B-Plasmablast\|Multiple_Sclerosis / Disease, Lineage and Cell Type	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.06e-05	174	74	5	e8d2aa9505817aac3fe068080774d19458f07b01
ToppCell	Healthy/Control-Plasmablast\|Healthy/Control / Disease group and Cell class	DTL POU2AF1 PKHD1L1 PARM1 MYBL2	1.06e-05	174	74	5	97d19ef3240a1f648c6befaabb9ce45ad469cbce
ToppCell	droplet-Kidney-nan-18m-Lymphocytic-T_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC9A9 SPN CD44 ARHGAP9 ZNF488	1.09e-05	175	74	5	82d48bfade1bc2f99848b45e55c8fb0ecc999ed7
ToppCell	COVID-19-lung-RBC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	C21orf58 TMEM131L MPIG6B PKHD1L1 MYBL2	1.09e-05	175	74	5	4c35292ad2ac712ba7516f27dd6eac6ba8fdd163
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLC9A9 SPN HLF CD44 RAB11FIP1	1.12e-05	176	74	5	0f55de48bbc396c187f2a7d1d7da20862c715f9e
ToppCell	droplet-Spleen-nan-21m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB32 SPN CD44 GNAS PARM1	1.12e-05	176	74	5	11067b649fe21ac2bb328829ecadc2f64c2c10aa
ToppCell	droplet-Spleen-nan-21m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB32 SPN CD44 GNAS PARM1	1.12e-05	176	74	5	130238f0707541c511f479619c4f7a3593ef0ebf
ToppCell	Control-Lymphoid_P-Plasmablast\|Control / Disease group, lineage and cell class	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.12e-05	176	74	5	4b4416f342b732d2cc60133838728880326257d8
ToppCell	Control-Lymphoid_P\|Control / Disease group, lineage and cell class	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.12e-05	176	74	5	d895a6b295cd649273ff80ad7785a3e0ae4c728a
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.15e-05	177	74	5	d2c1f46913ac00bbc0bb9320d5652edc01b34179
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.15e-05	177	74	5	65e090aad0ffb737ce034e25bd5b12a0b1dd9684
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.18e-05	178	74	5	6765c6970b1f2b719a20d2afd7471e1c262f3fc4
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.18e-05	178	74	5	693f1135d9c5545945e80c7ba3d098afc0ccac29
ToppCell	3'_v3-blood-Lymphocytic_B_plasma-Plasmablasts\|blood / Manually curated celltypes from each tissue	DTL POU2AF1 PKHD1L1 PARM1 MYBL2	1.22e-05	179	74	5	7d3bd1f9e126a4a9e0a84720a6cc0b3d235e65ee
ToppCell	10x5'-Lung-Lymphocytic_B_plasma-Plasmablasts\|Lung / Manually curated celltypes from each tissue	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.22e-05	179	74	5	3fa75eec3e86fd1797eaa33362257df7f9b2a0bf
ToppCell	BLOOD--(5)_Plasma\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.25e-05	180	74	5	1ac0a0a715f4a36df0762bb0de44802d6ffa284c
ToppCell	BLOOD--(5)_Plasmablasts\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.25e-05	180	74	5	4b9be1b19d4ecd0a3b924e4557a1ecfbcff2d705
ToppCell	3'_v3-blood-Lymphocytic_B_plasma\|blood / Manually curated celltypes from each tissue	DTL POU2AF1 PKHD1L1 PARM1 MYBL2	1.35e-05	183	74	5	2477183a290b2c45b6fa091ed76969a3826fe3d9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN4X CD44 RIMBP2 GNAS CASZ1	1.39e-05	184	74	5	d33de57876817050b294f2ecb0a4eb0634cfa7f0
ToppCell	Ciliated_cells-A-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	C21orf58 PRR29 MUC16 MUC5B TUBA4B	1.39e-05	184	74	5	07c5a9633ccdcd18771e3230d6198a55c400afa6
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cfh_(Cfh)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	SPN POU2AF1 RAB11FIP1 CA5A	1.42e-05	88	74	4	5582666aed9c1f465264f18898783872b662400d
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cfh_(Cfh)--\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	SPN POU2AF1 RAB11FIP1 CA5A	1.42e-05	88	74	4	5f774a85415d3cf163046f1154a82f749bf628fe
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cfh_(Cfh)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	SPN POU2AF1 RAB11FIP1 CA5A	1.42e-05	88	74	4	f59eeaba4a3c5ef03f741ed6a31fe88f57651374
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	C21orf58 PRR29 MUC16 CFAP74 TUBA4B	1.43e-05	185	74	5	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	critical-Myeloid-pDC\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	AEBP1 POU2AF1 PKHD1L1 PARM1 MYBL2	1.43e-05	185	74	5	4a5d1d0a757f1f4fdb911be96ed90b52182c25f0
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZBTB32 TTLL5 RAB11FIP1 PARM1 MYBL2	1.46e-05	186	74	5	55b239834b96b1f7787ec77a7d19796d617bbbf0
ToppCell	mild-Lymphocytic-Plasmablast\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.46e-05	186	74	5	060510c21b1e0889b7a6eeb15821b9e2f03a0f99
ToppCell	(101)_plasma\|World / immune cells in Peripheral Blood (logTPM normalization)	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.46e-05	186	74	5	16267994c9ef1fb7118c4c665cbc96979ec2b703
ToppCell	IPF-Lymphoid-B_Plasma\|Lymphoid / Disease state, Lineage and Cell class	POU2AF1 EIF2AK4 DCC PARM1 MYBL2	1.46e-05	186	74	5	f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.50e-05	187	74	5	88d20f150df61ef0e3ee0c3e9895b094920c4b09
ToppCell	Healthy_donor-B_memory\|World / disease group, cell group and cell class (v2)	ZBTB32 MUC16 POU2AF1 PKHD1L1 PARM1	1.50e-05	187	74	5	4f68e3243071a4549c80aff8bff32c6ad892ee7f
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.50e-05	187	74	5	158c2c003fd225ba61793fb06eece232fb063d05
ToppCell	control-Lymphocytic-Plasmablast\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.50e-05	187	74	5	94a44b31ce9fe6fb4758769018fb746e93c8f043
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.50e-05	187	74	5	d2296f2722a24b289fed7e6cfdc2105608437c3e
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.50e-05	187	74	5	06a0f0a27569af89f86ed8cddb608454a3d40cc5
ToppCell	severe_COVID-19-Plasmablast\|World / disease group, cell group and cell class (v2)	POU2AF1 DCC PKHD1L1 PARM1 MYBL2	1.54e-05	188	74	5	25ca19af4ac419a0f5026a6ccbd8b554b268a6f3
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.54e-05	188	74	5	ecba5d06cbf3254448255a2aeefffe711f43310e
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.54e-05	188	74	5	8cf135da4d1d2500755d2809d60b41509af9fa8b
ToppCell	(7)_Epithelial-F_(Ciliated)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	C21orf58 MUC15 PRR29 CFAP74 TUBA4B	1.54e-05	188	74	5	9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3
ToppCell	Severe_COVID-19-B_cell\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.58e-05	189	74	5	59ce8f15f413557d2059ee6b53ba5957b864cb8e
ToppCell	normal_Pleural_Fluid-B_lymphocytes-MALT_B_cells\|normal_Pleural_Fluid / Location, Cell class and cell subclass	POU2AF1 DCC PKHD1L1 PARM1 MYBL2	1.58e-05	189	74	5	05e8fb483ebb9010cc54b39d78cca960c58c0f01
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.58e-05	189	74	5	73ee4cfb1057832f700be59b6917dedde3e89880
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.58e-05	189	74	5	31594cc59eb1c5b01407dfd72b1487ecca8bf5ec
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF704 PKHD1 RIMBP2 CNGA1 CASZ1	1.58e-05	189	74	5	8ff3c3232eff9de4b5c9b22ecb82bc509d773f58
ToppCell	COVID-19_Mild-Lymphoid_P\|COVID-19_Mild / Disease group, lineage and cell class	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.58e-05	189	74	5	0b3d3bd697e79decae7e21c513fab9da3b2a47c5
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.58e-05	189	74	5	c296660061b46e3abae1e7cf29df20274e5a8add
ToppCell	COVID-19_Mild-Lymphoid_P-Plasmablast\|COVID-19_Mild / Disease group, lineage and cell class	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.58e-05	189	74	5	254f058850b41a5974a380f3710db7c01a51fb6b
ToppCell	Severe_COVID-19-Epithelial-undefined_Epi\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	MUC16 MUC5B TUBA4B PKHD1L1 MYBL2	1.58e-05	189	74	5	8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.58e-05	189	74	5	f2daf4889ef98bbefe3e44832618ac102a75b4d9
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZBTB32 POU2AF1 PKHD1L1 PARM1 MYBL2	1.58e-05	189	74	5	9de17ade3cc3e9cd1394338bd048fb1ce64ac50f
ToppCell	Healthy_donor-B_memory\|Healthy_donor / disease group, cell group and cell class (v2)	ZBTB32 MUC16 POU2AF1 PKHD1L1 PARM1	1.62e-05	190	74	5	46104a521f00d399315deca86699cb261b2795d6
Drug	CsCl	MUC3B HCN4 SPN MUC15 CD44 RIMBP2 MUC3A CNGA1	1.59e-08	136	75	8	CID000024293
Drug	rioprostil	MUC3B SPN MUC15 MUC3A	3.64e-06	32	75	4	CID005311413
Drug	cellobiitol	MUC3B SPN MUC15 MUC3A	6.60e-06	37	75	4	CID000003871
Drug	polylactosamine	HFE SPN MUC15 CD44 GNAS MYBL2	8.77e-06	146	75	6	CID000119065
Drug	mucic acid	MUC3B SPN MUC15 ADGRE2 MUC3A	1.07e-05	88	75	5	CID000000607
Drug	Gastrin tetrapeptide	MUC3B SPN MUC15 MUC3A	2.23e-05	50	75	4	CID000005415
Drug	Tn epitope	MUC3B SPN MUC15 MUC3A	3.26e-05	55	75	4	CID000447272
Disease	mean arterial pressure	HFE NFATC2 PKHD1 EIF2AK4 GNAS MTX1 CASZ1 RNF32-DT	2.65e-05	499	71	8	EFO_0006340
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MUC3A	5.01e-04	64	71	3	DOID:4947 (is_marker_for)
Disease	killer cell immunoglobulin-like receptor 2DS2 measurement	HLA-C KIR2DL4	5.87e-04	15	71	2	EFO_0801746
Disease	Anophthalmia-microphthalmia syndrome	OTX2 BCOR	1.16e-03	21	71	2	cv:C5680330
Disease	Precursor B-cell lymphoblastic leukemia	HLA-C HLF	1.16e-03	21	71	2	C1292769
Disease	susceptibility to Mycobacterium tuberculosis infection measurement	HLA-C NFATC2 TMEM131L	1.18e-03	86	71	3	EFO_0008407
Disease	Varicose veins	HLA-C NFATC2 GNAS CASZ1	1.22e-03	193	71	4	HP_0002619
Disease	red blood cell density measurement	ZNF704 OTX2 PKHD1 EIF2AK4 SAYSD1 MTX1 CASZ1 CNTN2	1.23e-03	880	71	8	EFO_0007978
Disease	Sjogren's syndrome (is_marker_for)	MUC19 MUC16	1.52e-03	24	71	2	DOID:12894 (is_marker_for)
Disease	Disorder of eye	OTX2 TPP1 BCOR CNGA1	1.73e-03	212	71	4	C0015397
Disease	Calcium channel blocker use measurement	NFATC2 GNAS MTX1 CASZ1	1.76e-03	213	71	4	EFO_0009930
Disease	cataract (is_implicated_in)	CRYBA1 BCOR	1.79e-03	26	71	2	DOID:83 (is_implicated_in)
Disease	Kallmann Syndrome	OTX2 DCC	1.79e-03	26	71	2	C0162809
Disease	RS-10-hydroxywarfarin to RS-warfarin ratio measurement	MUC3B EIF2AK4 MUC3A	2.40e-03	110	71	3	EFO_0803335

Protein segments in the cluster

Peptide	Gene	Start	Entry
APPLGSTTLPSTWTA	GNAS	251	P84996
PPPILSSSVEWSTSG	EIF2AK4	701	Q9P2K8
TWTPPPGVHSQTLSR	ADGRE2	266	Q9UHX3
ILTWLLSSLPSGSPP	ADGRG4	2006	Q8IZF6
PLPSSTITSSWNRIP	ADGRG4	2146	Q8IZF6
SPASVPSTPTLLAWK	CASZ1	1106	Q86V15
LSTTIEPWGLIPPTT	AEBP1	1061	Q8IUX7
WSPIPSGTVLSRSQP	EPN3	346	Q9H201
PGSLTVPPLLESVTW	CA13	196	Q8N1Q1
VSTPWQPPTVLLGHS	DTL	346	Q9NZJ0
IISTAPSSWVVPGPS	BCOR	501	Q6W2J9
PWGEIVSPSLSPATS	ADAMTS13	1306	Q76LX8
TPSSTPGTTWILTKP	MUC5B	1896	Q9HC84
SPGTALTPPVWISTT	MUC5B	2066	Q9HC84
SSSPGTALTPPVWIS	MUC5B	3321	Q9HC84
TPSSTPGTTWILTEP	MUC5B	3711	Q9HC84
PGTARTPPVWISTTT	MUC5B	3881	Q9HC84
GPTATPSSTPGTTWI	MUC5B	4406	Q9HC84
SSSPGTALTPPVWIS	MUC5B	4606	Q9HC84
LASSVTPGPSLWIPL	RNF32-DT	166	Q8NI28
PKTPSLSSTQPTRVW	RBSN	586	Q9H1K0
LSSTQPTRVWSGPPA	RBSN	591	Q9H1K0
PITPPTIVWTSTGTI	MUC16	1966	Q8WXI7
LTTAPPTWGIPQSTL	MUC16	2876	Q8WXI7
TASLPPLEWPLSSQS	NFATC2	391	Q13469
PWTPSLTLTPSLLTL	PLAC4	21	Q8WY50
SRSIKVSWLPPPSGT	DCC	636	P43146
TSPSVTPLIVEPSGW	MUC15	176	Q8N387
PPSTSINEGSPLWTS	SPN	66	P16150
PVPTISWLQNGLPFS	HMCN2	2881	Q8NDA2
STIRPGWLTVGPTLT	METTL14	351	Q9HCE5
QEPLTLSWEPSSQPT	HLA-C	291	P10321
TTVPLAGVTWTPGPS	MUC19	5961	Q7Z5P9
TWLSNSSVIPLPLPG	MUC3A	2871	Q02505
QPLIVIWEPSPSGTL	HFE	291	Q30201
SPTVPQSAFLGPTLW	HLF	56	Q16534
LPTNIVPPTTIWTSS	PARM1	31	Q6UWI2
AAASATPTPTPVIWT	HCN4	761	Q9Y3Q4
DPLPVSVTGNPSSSW	KIR2DL4	211	Q99706
GWLSQPTPATLQPLA	POU2AF1	86	Q16633
NTLHPLWTVPVSVPG	CA5A	46	P35218
LQSSLSSESWPIPEP	C4orf50	166	Q6ZRC1
NTTSGPIRTPQIPEW	CD44	636	P16070
SETPDSLQVSWTPPL	COL20A1	751	Q9P218
AATVLQPAPSLWTPG	C21orf58	306	P58505
TNPTPGSLGPWKITI	CRYBA1	21	P05813
SPQWTTAEPTLQIPS	CNTN2	281	Q02246
LVPSPQLWTVAPGFS	HELZ2	1896	Q9BYK8
PEPPSSWTGIRNTTQ	NLGN4X	91	Q8N0W4
SPITISPSVGTVWPG	CFAP74	1081	Q9C0B2
LGPSLWRVTPKSTSP	DELE1	16	Q14154
SAPVSIWSPASISPL	OTX2	146	P32243
WLSNNSVIPTPLPGV	MUC3B	786	Q9H195
ISNPWQSPSGTLPAL	MTX1	191	Q13505
PIAAPISTSTPIESW	RAB11FIP1	601	Q6WKZ4
VSWRPPVLTPTGLSN	RIMBP2	506	O15034
LTHSGPPLTTTLPEW	SLC9A9	541	Q8IVB4
NPSSWPVSLQLLPLS	TMEM131L	611	A2VDJ0
QGSLLTNWPSVPPTI	MYBL2	221	P10244
RPILWASSSGTPTVP	MPIG6B	61	O95866
SGEPTVPWDPSSTLL	NCAN	946	O14594
VPWDPSSTLLPVTLG	NCAN	951	O14594
SWSPKSAPILPGVVT	SPATA31E1	606	Q6ZUB1
QPTATASPRPGLWIT	DIP2C-AS1	36	Q8N8Z3
SLGPPSEPWTISASL	PKHD1	3776	P08F94
TNLVSYLTSTSPWPP	TUBA4B	196	Q9H853
WSTLTLTTIGETPPP	CNGA1	351	P29973
TTSWALLPPTLTSLG	ZNF488	256	Q96MN9
PTQWIATFGATITPP	TMPRSS11F	256	Q6ZWK6
LPWLPTSTVLITSPE	TREML4	141	Q6UXN2
SPLPSLSWVVAQSSP	PRR19	331	A6NJB7
LTGSQSAVWPSSPVP	PGF	171	P49763
PTSSPSAPVWLLSTL	VWCE	326	Q96DN2
QSPTTVIPGQLLWTP	ARHGAP9	91	Q9BRR9
SITNPLPSPSDSGWI	PKHD1L1	4046	Q86WI1
GSTSETPWNTAIPLP	SAYSD1	76	Q9NPB0
ISWQSPPVTFTGIPV	ZNF704	331	Q6ZNC4
KWVISLTPLSQPGPS	TMEM245	681	Q9H330
SAVPTPWVTFLQPLS	PRR29	16	P0C7W0
SPSQLPPGWTIRSTF	ZBTB32	451	Q9Y2Y4
SPSWTAPPVIALQNG	ZFAND2B	181	Q8WV99
PIISPSGPTWSTQSD	TTLL5	1081	Q6EMB2
VPIPWVSGTSASTPV	TPP1	466	O14773
AAGTPTPSLVWVLPN	MXRA5	2566	Q9NR99
SDPPTTTTLQPTIQW	NECTIN3	356	Q9NQS3